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ABSTRACT
De novo gene and genome synthesis enables the
design of any sequence without the requirement of
a pre-existing template as in traditional genetic
engineering methods. The ability to mass produce
synthetic genes holds great potential for biological
research, but widespread availability of de novo
DNA constructs is currently hampered by their
high cost. In this work, we describe a microfluidic
platform for parallel solid phase synthesis of
oligonucleotides that can greatly reduce the cost
of gene synthesis by reducing reagent consumption
(by 100-fold) while maintaining a  100pmol synthe-
sis scale so there is no need for amplification
before assembly. Sixteen oligonucleotides were
synthesized in parallel on this platform and then
successfully used in a ligation-mediated assembly
method to generate DNA constructs  200bp in
length.
INTRODUCTION
The ability to synthesize genes and genomes is a powerful
tool with a broad cross-section of applications, including
the study of large sets of genes, the design of genetic cir-
cuitry, and the engineering of metabolic pathways for the
production of small molecules. The basic concept of
de novo gene synthesis involves taking a pool of short
oligonucleotides and assembling them into larger con-
structs using some form of polymerase chain assembly
or ligase chain reaction approach (1,2). Traditional
methods of solid-phase oligonucleotide synthesis (3,4),
where each oligonucleotide is synthesized individually on
a separate column or in a multi-well plate, produce high
yields but are costly. For the assembly of long genes or
even whole genomic sequences, the cost of the starting
oligonucleotides alone can be prohibitive. Smaller-scale
synthesis strategies are needed to bring down the cost of
starting oligonucleotides before de novo gene synthesis will
be widely adopted.
The development of optical and electro-chemical
deprotection strategies have led to commercially available
DNA microarrays (5). Depending on the chip platform
being used, several thousand to several hundred thousand
distinctoligonucleotidescanbesynthesizedonasinglechip.
In principle, these massive parallel microarrays can reduce
the cost of oligonucleotides by orders of magnitude.
However, microarrays produce very small amounts of
oligonucleotides (10
7–10
8 molecules per sequence) (6).
Such low yields of oligonucleotides are insuﬃcient to
drive a gene assembly reaction and require additional
polymerase chain reaction (PCR) steps, which add com-
plexity. Another problem associated with microarray syn-
thesis technology is that all the oligonucleotides must be
cleaved oﬀ the chip as a single mixture. While the ability
to synthesize thousands or even hundreds of thousands of
oligonucleotides on a single chip is beneﬁcial, the sheer
number of diﬀerent strands synthesized on a chip requires
carefulplanningtohandlethecomplexityofallthepossible
interactions from the various sequences in the mixture (7).
Finally, in some cases oligonucleotides obtained from
microarray technologies can be of a lower quality
compared to existing solid-phase strategies due to a
deblocking step that is ineﬃcient.
Here, we report a programmable microﬂuidic synthesis
platform that addresses many of the limitations inherent
with current microarray DNA synthesis technologies.
Using conventional solid-phase chemistry, this device is
capable of synthesizing  100pmol of an oligonucleotide
sequence per column while consuming <250nl of 0.1M
phosphoramidite solution per column in each reaction
cycle. This is a substantial reduction ( 100-fold) in
reagent consumption compared to other solid-phase syn-
thesis technologies while keeping the product on a scale
large enough to not require subsequent ampliﬁcation
steps. The microﬂuidic architecture with integrated valves
allows one to individually manipulate and collect products
fromeachcolumn.Setsofoligonucleotideswithpotentially
disruptive interactions canbe separated intodiﬀerent pools
to avoid problems in gene assembly. Furthermore, this
platform lends itself to further integration with other pro-
cesses including gene assembly, cloning, or puriﬁcation on
chip (7–9). As a proof of principle, we synthesized 16
oligonucleotides on a single device; without further puriﬁ-
cation, we successfully used these sequences to assemble a
DNA construct  200bp long.
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Microﬂuidic oligonucleotide synthesizer
The parallel microfuidic DNA synthesizer, shown in
Figure 1, was fabricated using a standard multilayer soft
lithography (MSL) method (10,11). The device can be
roughly divided into three components. The front compo-
nent handles all the reagents. In each synthesis step, the
valve for the desired reagent opens while others remain
closed, delivering the appropriate reagent by means of
back pressure. The middle component consists of a
binary tree which produces a uniform ﬂow rate across
all reaction columns. The herringbone topology within
the binary tree facilitates proper mixing of reagents as
shown in Supplementary Movie M1. The total volume
of the binary tree is 1.49ml. The end component consists
of a 16-column array. The column array was designed to
allow parallel loading of solid supports. Purge lines were
implemented to avoid cross contamination between syn-
thesis steps by properly purging residual reagent within
the binary tree. Each reaction column measures 4500mm
long, 200mm wide and 30mm tall to give a column volume
of 27nl. Additional sieve valves (denoted as compression
valves) were added to the middle of the columns to
prevent rearrangement of closely packed spherical beads
when a pressure drop occurs between synthesis steps,
minimizing bead loss. Over 95% of resin was retained
after 40 cycles (20h) of synthesis.
Device preparation and operation
Microﬂuidic devices were stored in a desiccator overnight
before use. Glass vials ﬁlled with molecular sieves and
steel tubes (New England Small Tube Co., Litchﬁeld,
NH) were dried in a 180 C oven overnight and allowed
to cool to room temperature 15min prior to use.
The control lines were interfaced with computer-controled
solenoid valves (Pneumadyne, Plymouth, MN) through
steel tubes connected to Tygon tubing. The control lines
were primed with Krytox oil through dead-end ﬁlling.
All reagents were prepared fresh prior to experiments.
Glass vials ﬁlled with reagent were connected to the
device via microbore PTFE tubing through the septa.
Control porous silica beads (5mm, 500A ˚ ) functionalized
with universal linker (SynGen) were used to construct the
bead columns as described in Supplementary Figure S1.
Both reagent delivery (10psi for acetonitrile, 5psi for
everything else) and valve actuation (35psi) were con-
troled using argon gas.
Microﬂuidic oligonucleotide synthesis
The synthesis used standard phosphoramidite chemistry
(12,13) except for the deprotection step, where 10%
triﬂuoroacetic acid in acetonitrile was used to ensure sol-
vent compatibility with polydimethylsiloxane (PDMS).
Short oligonucleotides  15–25-nt in length can be
synthesized without any capping step. Oligonucleotides
>40nt in length required a capping step to achieve high
yield of full-length product. Each synthesis cycle con-
tained seven reaction steps and four washing steps. The
step-sequence was deblocking (1.8min), washing (4min),
coupling T (2.5min), coupling G (2.5min), coupling A
(2.5min), coupling C (2.5min), washing (1min), capping
(2.5min), washing (2min), oxidizing (2min), washing
(2min). An extended deblocking condition of 2.5min
Figure 1. (A) Schematic diagram of a 16-column microﬂuidic DNA synthesizer. The control lines are shown in red, the ﬂuidic lines in blue, the
herringbone mixers in yellow, and the square proﬁled binary tree and reactor columns in green. (B) Close up schematic of the column array. The red
and yellow valves close fully when activated; the blue and green valves are sieve valves that allow ﬂuid ﬂow while trapping CPG beads. Each column
has a ﬂush valve that opens and closes in unison to allow residual reagent in the binary tree to be washed away between steps to avoid contam-
ination. The addressable inlet valve controls which columns the reagents enter. The compression valves prevent rearrangement of closely packed
spherical beads when a pressure drop occurs between steps.
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removal of the dimethoxytrityl (DMT) group from the
secondary hydroxyl group of the universal linker. The
initial coupling step to the universal linker was run for
3min instead of the normal 2.5min. During the coupling
step, the two coupling reagents (phosphoramidite and
activator) were sent through the reaction columns alter-
nately with one reagent ﬂowed continuously for 0.27s
followed by the other for 0.27s before cycling. The ﬁnal
deblocking of the ﬁnished oligonucleotides was done by
ﬂowing deblocking reagent into reaction columns for
2min. After an extended acetonitrile wash, we released
the ‘column valves’ and ﬂushed the beads out of the
chip and into micro-centrifuge tubes. The acetonitrile
was evaporated using centri-vap. In the ﬁnal cleavage
step, 75ml concentrated ammonium hydroxide was
added into the tubes and then incubated at 55 C for
12h. The beads were centrifuged and then the liquid
phase was transferred into new tubes and lyophilized to
yield oligonucleotides as pellets (with salts).
Polyacrylamide gel electrophoresis
The synthesized oligonucleotides were re-suspended
in water and normalized to a concentration of 50ng/ml
using a NanoDrop 1000 (Thermo Scientiﬁc). Before gel
loading, the oligonucleotides were mixed with TBE–
Urea sample loading buﬀer (Invitrogen) and heated
to 70 C for 3min. Samples of 1.5ml were loaded onto
polyacrylamide gel (15% Novex TBE–Urea gel,
Invitrogen). Samples  20nt in length were run at room
temperature at 175V for 75min. Samples  40-nt in length
were run under the same condition but for 100min.
The gels were stained with SYBR Gold dye and visualized
using Typhoon 9410 (Amersham Biosciences). Final
images were analyzed using ImageQuant (Amersham
Biosciences).
Design of oligonucleotides for gene synthesis
A gene fragment from Bacillus cereus was selected for
synthesis through a ligation mediated assembly method.
Oligonucleotide sequences were derived from a
custom-developed program that ﬁrst divides the
sequence into oligonucleotides with a desired melting tem-
perature range while keeping track of the melting temper-
ature variation between the pieces. The set of pieces with
the least variation in melting temperature was chosen.
The program then generated the sequence of the sense
strand by stitching every two pieces together, and the
anti-sense strand using the same method but with an
oﬀset of a single piece. A summary of the oligonucleotide
set is provided in Table 1.
Ligation assembly of DNA constructs
Each oligonucleotide strand (8ml, 5mM) was mixed with
1ml of T4 polynucleotide kinase reaction buﬀer (New
England Biolabs) and 1ml of 10mM ATP, then cooled
to 4 C. T4 polynucleotide kinase (0.7ml) was then
added. The mixture was allowed to react for 1h at 37 C
and then terminated by heating the reaction mixture to
65 C for 15min. The phosphorylated oligonucleotides
were then added together and diluted into a 75nM
solution. One microliter of Taq DNA ligase reaction
buﬀer and 0.75ml of Taq DNA ligase were added to 9ml
of phosphorylated oligonucleotide solution. The mixture
was heated to 65 C for 30s to ensure all the
oligonucleotides were melted oﬀ. The ligation reaction
was then allowed to take place at 42 C for 4h.
PCR of ligation product
Polymerase chain reaction was performed with 100mlo f
reaction mixture including 10ml PCR buﬀer, 3mlo f
50mM MgCl2,2ml of Primer A1 (10mM), 2ml of Primer
B1 (10mM), 1ml of dNTPs, 1ml of ligation mixture. The
PCR was conducted using the following conditions: 2min
initial denaturation at 94 C, then 20 cycles of 94 C for
45s, 55 C for 30s, 72 C for 1.5min.
DNA sequencing
PCR products were sequenced to check for errors. The
DNA construct was cloned using plasmid vector
pCR4-TOPO (Invitrogen) and transformed into chemi-
cally competent OneShot TOP10 chemically competent
Escherichia coli cells. The cells were spread on prewarmed
LB plates containing 50–100mg/ml ampicillin and
incubated at 37 C. After overnight growth, the plates
were sent to Molecular Cloning Laboratories (MCLab)
where individual colonies were ampliﬁed and sequenced.
RESULTS
Microﬂuidic oligonucleotide synthesis
A PDMS-based microﬂuidic device was used as a
miniaturized synthesizer for solid-phase parallel synthesis
of oligonucleotides. This device has 16nl-scale reaction
chambers as illustrated in Figure 1B. Smaller, more
compact reaction columns are also possible using the
same fabrication method. The 100pmol synthesis scale is
chosen so that suﬃcient products are produced for several
ligation assembly reactions after standard analysis
methods. This device allows more than an order of mag-
nitude higher synthesis throughput than the single reactor
chemical DNA synthesizer we described previously (14).
In a typical experiment, oligonucleotide synthesis starts
on universal linker-derivatized controlled porous glass
beads (15). During operation, appropriate reagents are
driven by pressure into binary trees that precede the
reaction columns. Each reaction column is gated by an
individually addressable valve that not only controls
which phosphoramidite solution enters the column but
also allows varied exposure time of solutions to that
column if necessary. Because each reaction column is
physically separated from the others, the reaction
cross-talk between adjacent columns is minimized.
Potential contamination between synthesis steps when
residual reagents might enter reactors is eliminated by
adequate ﬂushing of the binary tree after each step. In
addition, by physically separating the columns, the
contents of each column can be selectively eluted, unlike
2516 Nucleic Acids Research, 2010,Vol.38, No. 8microarray technologies where all the products are cleaved
oﬀ into a single mixture.
Each reaction column consumes  250nl of 0.1M
phosphoramidite solution in each reaction cycle, a sub-
stantial savings (>100-fold) over conventional DNA
synthesizers on a per sequence basis. More importantly,
unlike other microarray technologies where only
femtomoles of each oligonucleotide are synthesized, the
100pmol synthesis scale allows direct gene assembly
without any need for ampliﬁcation which increases cost
and oligonucleotide length to accommodate adapters
before assembly.
Synthesis of oligonucleotide using triﬂuoroacetic
acid deblocking
Because dichloromethane is incompatible with PDMS and
leads to swelling and possible delamination of multilayer
devices (16), acetonitrile is the preferred solvent. However,
the reagent traditionally used for deblocking
(dichloroacetic acid) forms a complex with acetonitrile
that drastically slow detritylations (17). Therefore, a new
deblocking solution that is more suitable for PDMS
devices had to be formulated.
Heterogeneous phase detritylation processes are
complex with many chromatography eﬀects such as the
retardation of detritylation due to acid binding with the
oligonucleotides and recapture of free DMT cation by
50-OH group. In addition, the interplay of incomplete
deblocking and losses of oligonucleotide bases due to
depurination make rigorous kinetic modeling and
analysis diﬃcult. We analyzed the end product of the syn-
thesis and used the ratio of full-length product to
truncated byproducts as a benchmark to evaluate the
success of the deblocking step.
We surveyed several deblocking solutions composed of
diﬀerent organic acids in acetonitrile using spectroscopy
to detect the release of the colored DMT cation when
beads are exposed to these solutions. The deblocking solu-
tions that release the most DMT cation were used in the
synthesis of the homopolymer A20. Adenine was chosen
because it is the base most sensitive to depurination (18).
We found that triﬂuoroacetic acid was most suitable
(Figure 2). Initially, we established that 5% TFA in
acetonitrile with a deblocking time of 2.5min was suﬃ-
cient for synthesis of short oligonucleotides. However, in
experiments where long oligonucleotides (longer that
35mers) were synthesized, we observed that the orange
color of DMT cation persists well over the 2.5min
deblocking time at later synthesis cycles. We believe that
acid binding to the growing oligonucleotide depletes free
acid from the deblocking solution at higher oligo-
nucleotide mass densities due to the increased length.
We addressed this problem by increasing the deblocking
acid concentration to 10%. The use of higher acid concen-
tration allows quicker saturation and gives faster and
more complete detritylation. In subsequent experiments
where 10% TFA in acetonitrile was chosen as the
deblocking solution, the optimum deblocking time was
found to be between 1 and 2min (Table 2). At longer
deblocking times, losses of full-length nucleotide product
through depurination exceeded gains from increased
deblocking eﬃciency.
Using the established synthesis protocol with our
deblocking conditions, we proceeded to synthesize the
oligonucleotides needed to assemble a gene fragment
from B. cereus. Each oligonucleotide product was
veriﬁed though gel electrophoresis. The gel image
(Figure 3) shows that the chip products had the same
motility as commercially ordered standards from
Integrated DNA Technologies (IDT). The lanes with
chip products were partially smeared because no desalting
step was taken; however, the major products all corre-
sponded with full-length oligonucleotides.
To test the limits of this synthesis method, we also
synthesized oligonucleotides up to 40 bases in length.
We found that at these lengths, the resulting oligo-
nucleotides were not of suﬃciently high quality for
assembly. We therefore added an additional capping
step that was not used in our original synthesis of
shorter oligonucleotides. By capping unreacted bases, we
prevented truncated sequences from extending further.
This eliminated most of the N-1 and N-2 oligonucleotides
observed in the uncapped synthesis, which are particularly
problematic because they can lead to deletion errors in the
gene assembly reaction. PAGE analysis of the reactions
(Figure 4) shows that the dominant bands in the capped
synthesis are from full-length product as opposed to
truncated products from the uncapped synthesis. By
comparing the ratio of full-length product to the
N-1-mers, we calculated our deblocking eﬃciency to be
>98.6%.
Table 1. Oligonucleotide sequences used for the ligation-mediated assembly of a gene fragment of B. cereus
Forward sequence Reverse sequence
F1 GTATACTTCCAATCCAATGCA R1 TCGCTTTCATTGCATTGGAT
F2 ATGAAAGCGAAGAAAAAAGATAAA R2 ATATTCAGAAGTTTTATCTTTTTTCT
F3 ACTTCTGAATATCAGTACGTTG R3 ACCATGCGTCAACGTACTG
F4 ACGCATGGTACTCTAATCAG R4 CGGCCGTTCTGATTAGAGT
F5 AACGGCCGTAGCATCCC R5 ACGTTTCCACGGGATGCTA
F6 GTGGAAACGTATCCCGTCC R6 CACTTCGCTGGACGGGAT
F7 AGCGAAGTGAAACAGTTCCA R7 CACCGGTCTGGAACTGTTT
F8 GACCGGTGAGGCGTTCA R8 ACAGTTGAAGTTGAACGCCT
F9 ACTTCAACTGTTTCGCAACTGTTCAGCGTTTC
The similar starting sequences of F3 and F9 that led to side products during the assembly are in bold.
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To conﬁrm the identity of synthesized sequences and to
determine whether the eluted oligonucleotides were func-
tional without further ampliﬁcation or puriﬁcation, a gene
fragment from B. cereus was assembled from a mixture of
oligonucleotide 17–24-mers that was obtained using the
microﬂuidic synthesis method described earlier. The
general strategy of gene assembly used involves ligation
of oligonucleotides into a complete construct followed by
PCR ampliﬁcation of the full-length product (Figure 5).
The 230-bp gene fragment sequence and its component
oligonucleotides are given in the Supplementary Data.
The oligonucleotides were each collected in a 10ml
volume; the material produced from one synthesis is suf-
ﬁcient for 50–100 ligation reactions.
A special set of ligation reactions with Cy3-labeled F1
strand was performed to examine the ligation reaction in
detail by gel electrophoresis without the need of ampliﬁ-
cation (Figure 6). Reaction pots with increasing numbers
of strands that form products of increasing length were
prepared. We expected species of various starting and
ending strands to be ligated in each reaction. However,
only species that included the Cy3-labeled F1 strand
could be visualized after electrophoresis.
Our results show that no products longer than
the expected length are present in each reaction mixture.
In general, the amount of ligation product decreases as the
number of ligation steps needed to form a particular
product increases. The majority of the Cy3-labeled F1
strands failed to take part in any ligation reaction to
form longer products. The longest detectable ligation
product without further ampliﬁcation is F1–F7.
The yield of this ligation reaction was not optimized.
PCR of ligation product
We performed PCR of the ligation reactions and analyzed
the results on an agarose gel. Strong bands were evident
for the desired product in lanes with the full set of starting
Figure 4. Polyacrylamide gel electrophoresis showing oligonucleotides
40 bases in length synthesized under diﬀerent conditions. Lane 1 is a
puriﬁed standard purchased from IDT. Lane 2 is product synthesized
using the microﬂuidic chip using 5% TFA deblocking solution without
any capping during the synthesis. Lanes 3 and 4 are products from
diﬀerent reaction columns synthesized using 10% TFA deblocking
solution with capping after each synthesis cycle. The gel image shows
that the dominant bands in the capped synthesis are from full-length
products whereas there are a large number of truncated products in the
uncapped synthesis.
Figure 3. Polyacrylamide gel electrophoresis comparing oligonu-
cleotides synthesized from the microﬂuidic platform (Ch) to
oligonucleotides purchased from IDT. The chip products have the
same motility as the commercially-prepared standards. However, the
chip products are also partially smeared because of excess salt as no
desalting step was performed after cleavage from the beads.
Figure 2. Eﬀect of deblocking acids and deblocking times on the
quality of A20 homopolymer. A selection of organic acids is broadly
surveyed as candidates to be used in an acetonitrile based deblocking
solution. Five percent TFA is found to be more suitable than 10%
DCA and 10% TCA with an optimal deblocking time between 2:00
and 2:30min.
Table 2. Eﬀect of deblocking time on the length distribution of A40
homopolymer using 10% TFA in acetonitrile
Length Deblocking time
0s 30s 1min 1.5min 2.0min 2.5min 3.0min 3.5min
N 0 0.351 0.671 0.651 0.656 0.644 0.644 0.598
N 1 0 0.284 0.329 0.349 0.344 0.356 0.356 0.402
N 2 0 0.214
N 3 0 0.151
A minimum of 1min deblocking time is needed for successful deblock.
The quality of the homopolymer starts to drop with deblocking time
above 2.5min. This suggests that increase deblocking eﬃciency at
longer time is oﬀset by losses of full-length product through
depurination.
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cleotide sets used as controls yielded no product-length
bands, conﬁrming that the presence of desired-length
species was not a consequence of ampliﬁcation of a
contaminating species. We observed a weak band in the
main reaction lanes that indicated there were lower molec-
ular weight species present that could be assembly inter-
mediates present in the ligation product (Figure 7).
DNA sequencing of assembled sequence
Sequencing of microﬂuidic gene synthesis products
unambiguously conﬁrmed the identity of the gene con-
struct. Even though such sequencing does not directly
report on the quality of the starting synthesized oligo-
nucleotides, errors present in the starting oligonucleotides
would be a source of deletions and other errors in the
assembled sequences. The ﬁdelity of the polymerase used
in ampliﬁcation step may also contribute to any observed
errors (8).
Gel puriﬁcation of the resulting assembled sequence was
omitted to prevent the masking of errors. The clones were
also not screened prior to sequencing other than to
conﬁrm successful insertion into the cloning vector.
Thus, gene assembly products including both full-length
species along with other incomplete, intermediate
products should be detected in the clones.
Ten randomly selected clones of DNA constructs
assembled from puriﬁed oligonucleotides purchased from
IDT were sequenced. Eighteen randomly selected clones
of DNA constructs assembled from oligonucleotides
synthesized on the microﬂuidic synthesis chip (Chip)
Figure 5. Schematic of gene assembly by ligation. The starting oligos are placed in a single mixture and allowed to anneal and ligate into complete
constructs. Primers are then added to amplify the full-length product by PCR.
Figure 6. Polyacrylamide gel electrophoresis for a series of ligation
reactions with a Cy3-labeled F1 strand in combination with diﬀerent
numbers of starting oligonucleotides. No products longer than the
expected length are present in each reaction mixture. For example, in
the mixture containing F1 through F5, only F1, F1–F2, F1–F3, F1–F4
and F1–F5 are observed. No products longer than F1–F7 can be
visualized without further ampliﬁcation. In general, the amount of
ligation product decreases as the number of ligation steps needed to
form a particular product increases.
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summarized in Table 3.
Out of the 10 IDT clones, eight have perfect sequence
while two had single deletions. Out of the 18 Chip clones,
four had perfect sequences, ﬁve had single deletions, two
had single point mutations, one had a single deletion and
insertion, and one had single point mutation and a single
insertion. More interestingly, three of the chip clones were
missing a stretch of sequence from F3 to F8. Looking
more closely at the sequences of the starting
oligonucleotides, we found that the ﬁve starting bases
for F3 were identical to F9. Thus, F9 can incorrectly
ligate to F2 instead of F3. Such a problem could be
avoided with more careful design of the starting
oligonucleotide pool.
For the IDT clones, a total of two errors were found out
of 1300 bases sequenced, an error rate of 1 per 650bp or
0.15%. Excluding clones with incompletely assembled
sequences, the Chip clones had 11 errors out of 1690
bases sequenced. That is an error rate of 1 per 153bp or
0.65%. This error rate is very similar to the error of 1 in
160bp given by Tian (19).
DISCUSSION
In this study we have developed a microﬂuidic synthesis
platform capable of generating a number of
oligonucleotides in parallel for gene assembly. This
system addresses many of the limitations associated with
microarray technology that may lead to reduced product
purity such as deprotection, insuﬃcient synthesis scale,
and adverse interactions in large oligonucleotide
pools while keeping many of its advantages such as
reduced cost. Our chip is programmable for synthesis of
any desired sequence, easy to operate and consumes
minute quantities of reagent and solvent on a per
sequence basis.
The physical separation of individual reaction chambers
eliminates the potential problem of cross contamination.
Having individually addressable valves gating each
reaction chamber also allows for easy recovery of
speciﬁc sequences synthesized for direct use in the subse-
quent gene assembly. This is especially useful for multiplex
reactions where sequences with adverse interactions with
each other can be eluted into diﬀerent mixtures. Such
precise ﬂuid handling is not available in microarray
technologies and will help allow the integration of this
chip to other processes in the future.
The oligonucleotides synthesized from our device were
directly used for ligation to give DNA constructs  200-bp
long. Employing such direct synthesis without concentra-
tion or an initial ampliﬁcation step not only reduces the
time and cost of the overall synthesis protocol, but also
eliminates the possibility that additional errors will be
generated during the ampliﬁcation procedure. While the
error rate of 1 in 153bp from chip product is higher than
that observed for a product assembled from puriﬁed
oligonucleotides ordered from IDT, it is consistent with
the 1 in 160bp error rate given by Tian for assembly of
DNA constructs using unpuriﬁed oligonucleotides. The
17–24-mer synthesis also lacked capping; given the
improvement in purity for longer syntheses (Figure 3),
performing capping during the synthesis of the
oligonucleotides used for ligation should also improve
the error rate. Optimized ligation conditions, including
varied temperature, may also be able to minimize the
incorporation of errors into the full-length product.
These results demonstrate signiﬁcant progress towards
high-throughput gene synthesis and could help meet the
growing demands of this emergent ﬁeld of synthetic
biology. Substantial improvements are still needed but
many can still be achieved through further optimization
of reaction conditions. Systems integration of other pro-
cesses that have already been demonstrated in stand-alone
units, such as puriﬁcation, cloning and protein expression
(20) will greatly increase the range of suitable applications
for this technology.
SUPPLEMENTARY DATA
Supplementary Data is available at NAR Online.
Table 3. Summary of errors in the assembly of a gene fragment of
Bacillus cereus using puriﬁed oligonucleotides purchased commercially
(IDT clones) versus the synthesis products from the microﬂuidic
device (Chip clones)
Error type IDT
assembly of
oligos
Chip
assembly of
oligos
None 8/10 4/18
Single deletion 2/10 5/18
Single mutation 2/18
Single insertion and deletion 1/18
Single insertion and mutation 1/18
Sequence truncation (missing
oligos)
5/18
Total bases sequenced 1300 1690
(without
truncation)
Overall assembly success rate 80% 22%
Total number of errors 2 11
Per base error rate 1 in 650 1 in 153
Figure 7. Agarose gel electrophoresis showing full-length assembly of a
gene fragment from B. cereus. In the presence of the full set of starting
oligos, full-length products are observed following ampliﬁcation.
‘Primer-only’ and incomplete oligonucleotide sets used as controls
yielded no product-length bands. Weaker bands with lower molecular
weight indicate assembly intermediates present in the ligation product.
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